Ligand source activities (1 row/activity)
| Ligands (move mouse cursor over ligand name to see structure) | Receptor | Activity | Chemical information | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
| |
Ligands (move mouse cursor over ligand name to see structure)
| Receptor
| Activity
| Chemical information
| |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
| |
| 17725 | 15592 | None | 53 | Human | Functional | pEC50 | = | 4 | 4.0 | - | 1 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 132 | 0 | 0 | 1 | 0.4 | CN(C)C(=S)N(C)C | nan | ||
| CHEMBL12214 | 15592 | None | 53 | Human | Functional | pEC50 | = | 4 | 4.0 | - | 1 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 132 | 0 | 0 | 1 | 0.4 | CN(C)C(=S)N(C)C | nan | ||
| 2723593 | 173351 | None | 36 | Human | Functional | pEC50 | = | 4.8 | 4.8 | - | 1 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 118 | 0 | 2 | 2 | -0.6 | CC(=O)NC(N)=S | nan | ||
| CHEMBL4524588 | 173351 | None | 36 | Human | Functional | pEC50 | = | 4.8 | 4.8 | - | 1 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 118 | 0 | 2 | 2 | -0.6 | CC(=O)NC(N)=S | nan | ||
| 820777 | 136791 | None | 49 | Human | Functional | pEC50 | = | 4.8 | 4.8 | - | 1 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 151 | 1 | 1 | 1 | 2.4 | CC(=S)Nc1ccccc1 | nan | ||
| CHEMBL3740596 | 136791 | None | 49 | Human | Functional | pEC50 | = | 4.8 | 4.8 | - | 1 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 151 | 1 | 1 | 1 | 2.4 | CC(=S)Nc1ccccc1 | nan | ||
| 12496 | 3101 | None | 59 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 2 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 152 | 1 | 2 | 1 | 1.3 | C1=CC=C(C=C1)NC(=S)N | nan | ||
| 676454 | 3101 | None | 59 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 2 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 152 | 1 | 2 | 1 | 1.3 | C1=CC=C(C=C1)NC(=S)N | nan | ||
| CHEMBL263376 | 3101 | None | 59 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 2 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 152 | 1 | 2 | 1 | 1.3 | C1=CC=C(C=C1)NC(=S)N | nan | ||
| DB03694 | 3101 | None | 59 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 2 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 152 | 1 | 2 | 1 | 1.3 | C1=CC=C(C=C1)NC(=S)N | nan | ||
| 2308 | 3188 | None | 68 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 34 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 170 | 2 | 2 | 2 | 1.4 | CCCc1cc(=O)[nH]c(=S)[nH]1 | nan | ||
| 657298 | 3188 | None | 68 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 34 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 170 | 2 | 2 | 2 | 1.4 | CCCc1cc(=O)[nH]c(=S)[nH]1 | nan | ||
| 6650 | 3188 | None | 68 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 34 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 170 | 2 | 2 | 2 | 1.4 | CCCc1cc(=O)[nH]c(=S)[nH]1 | nan | ||
| CHEMBL1518 | 3188 | None | 68 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 34 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 170 | 2 | 2 | 2 | 1.4 | CCCc1cc(=O)[nH]c(=S)[nH]1 | nan | ||
| DB00550 | 3188 | None | 68 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 34 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 170 | 2 | 2 | 2 | 1.4 | CCCc1cc(=O)[nH]c(=S)[nH]1 | nan | ||
| 700999 | 98422 | None | 55 | Human | Functional | pEC50 | = | 5.6 | 5.6 | - | 1 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 228 | 2 | 2 | 1 | 3.5 | S=C(Nc1ccccc1)Nc1ccccc1 | nan | ||
| CHEMBL275260 | 98422 | None | 55 | Human | Functional | pEC50 | = | 5.6 | 5.6 | - | 1 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 228 | 2 | 2 | 1 | 3.5 | S=C(Nc1ccccc1)Nc1ccccc1 | nan | ||
| 1499 | 2091 | None | 34 | Human | Functional | pEC50 | = | 8.3 | 8.3 | -63 | 38 | Agonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay |
ChEMBL | 211 | 4 | 4 | 4 | 1.1 | CC(NCC(c1ccc(c(c1)O)O)O)C | nan | ||
| 3779 | 2091 | None | 34 | Human | Functional | pEC50 | = | 8.3 | 8.3 | -63 | 38 | Agonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay |
ChEMBL | 211 | 4 | 4 | 4 | 1.1 | CC(NCC(c1ccc(c(c1)O)O)O)C | nan | ||
| 3779.0 | 2091 | None | 34 | Human | Functional | pEC50 | = | 8.3 | 8.3 | -63 | 38 | Agonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay |
ChEMBL | 211 | 4 | 4 | 4 | 1.1 | CC(NCC(c1ccc(c(c1)O)O)O)C | nan | ||
| 536 | 2091 | None | 34 | Human | Functional | pEC50 | = | 8.3 | 8.3 | -63 | 38 | Agonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay |
ChEMBL | 211 | 4 | 4 | 4 | 1.1 | CC(NCC(c1ccc(c(c1)O)O)O)C | nan | ||
| CHEMBL434 | 2091 | None | 34 | Human | Functional | pEC50 | = | 8.3 | 8.3 | -63 | 38 | Agonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay |
ChEMBL | 211 | 4 | 4 | 4 | 1.1 | CC(NCC(c1ccc(c(c1)O)O)O)C | nan | ||
| DB01064 | 2091 | None | 34 | Human | Functional | pEC50 | = | 8.3 | 8.3 | -63 | 38 | Agonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay |
ChEMBL | 211 | 4 | 4 | 4 | 1.1 | CC(NCC(c1ccc(c(c1)O)O)O)C | nan | ||
| 697057 | 15283 | None | 67 | Human | Functional | pEC50 | = | 6.3 | 6.3 | - | 1 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 204 | 1 | 2 | 2 | 2.1 | O=c1cc(-c2ccccc2)[nH]c(=S)[nH]1 | nan | ||
| CHEMBL1212975 | 15283 | None | 67 | Human | Functional | pEC50 | = | 6.3 | 6.3 | - | 1 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 204 | 1 | 2 | 2 | 2.1 | O=c1cc(-c2ccccc2)[nH]c(=S)[nH]1 | nan | ||
| 69794 | 173622 | None | 47 | Human | Functional | pEC50 | = | 4.3 | 4.3 | - | 1 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 89 | 1 | 0 | 1 | 0.5 | CN(C)C=S | nan | ||
| CHEMBL4530853 | 173622 | None | 47 | Human | Functional | pEC50 | = | 4.3 | 4.3 | - | 1 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
ChEMBL | 89 | 1 | 0 | 1 | 0.5 | CN(C)C=S | nan | ||
| 2308 | 3188 | None | 68 | Human | Functional | pEC50 | = | 8.2 | 8.2 | 34 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
Drug Central | 170 | 2 | 2 | 2 | 1.4 | CCCc1cc(=O)[nH]c(=S)[nH]1 | None | ||
| 657298 | 3188 | None | 68 | Human | Functional | pEC50 | = | 8.2 | 8.2 | 34 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
Drug Central | 170 | 2 | 2 | 2 | 1.4 | CCCc1cc(=O)[nH]c(=S)[nH]1 | None | ||
| 6650 | 3188 | None | 68 | Human | Functional | pEC50 | = | 8.2 | 8.2 | 34 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
Drug Central | 170 | 2 | 2 | 2 | 1.4 | CCCc1cc(=O)[nH]c(=S)[nH]1 | None | ||
| CHEMBL1518 | 3188 | None | 68 | Human | Functional | pEC50 | = | 8.2 | 8.2 | 34 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
Drug Central | 170 | 2 | 2 | 2 | 1.4 | CCCc1cc(=O)[nH]c(=S)[nH]1 | None | ||
| DB00550 | 3188 | None | 68 | Human | Functional | pEC50 | = | 8.2 | 8.2 | 34 | 2 | Activity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assayActivity at human TAS2R38 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as effect on calcium response by FLIPR assay |
Drug Central | 170 | 2 | 2 | 2 | 1.4 | CCCc1cc(=O)[nH]c(=S)[nH]1 | None | ||
| 1499 | 2091 | None | 34 | Human | Functional | pEC50 | = | 8.1 | 8.1 | -63 | 38 | Agonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay |
Drug Central | 211 | 4 | 4 | 4 | 1.1 | CC(NCC(c1ccc(c(c1)O)O)O)C | None | ||
| 3779 | 2091 | None | 34 | Human | Functional | pEC50 | = | 8.1 | 8.1 | -63 | 38 | Agonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay |
Drug Central | 211 | 4 | 4 | 4 | 1.1 | CC(NCC(c1ccc(c(c1)O)O)O)C | None | ||
| 3779.0 | 2091 | None | 34 | Human | Functional | pEC50 | = | 8.1 | 8.1 | -63 | 38 | Agonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay |
Drug Central | 211 | 4 | 4 | 4 | 1.1 | CC(NCC(c1ccc(c(c1)O)O)O)C | None | ||
| 536 | 2091 | None | 34 | Human | Functional | pEC50 | = | 8.1 | 8.1 | -63 | 38 | Agonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay |
Drug Central | 211 | 4 | 4 | 4 | 1.1 | CC(NCC(c1ccc(c(c1)O)O)O)C | None | ||
| CHEMBL434 | 2091 | None | 34 | Human | Functional | pEC50 | = | 8.1 | 8.1 | -63 | 38 | Agonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay |
Drug Central | 211 | 4 | 4 | 4 | 1.1 | CC(NCC(c1ccc(c(c1)O)O)O)C | None | ||
| DB01064 | 2091 | None | 34 | Human | Functional | pEC50 | = | 8.1 | 8.1 | -63 | 38 | Agonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R38 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay |
Drug Central | 211 | 4 | 4 | 4 | 1.1 | CC(NCC(c1ccc(c(c1)O)O)O)C | None | ||
| 1349907 | 2499 | None | 0 | Human | Functional | pEC50 | = | 4.0 | 4.0 | - | 1 | UnclassifiedUnclassified |
Guide to Pharmacology | 114 | 0 | 1 | 3 | 0.7 | Cn1ccnc1S | 23632915 | ||
| 1745 | 2499 | None | 0 | Human | Functional | pEC50 | = | 4.0 | 4.0 | - | 1 | UnclassifiedUnclassified |
Guide to Pharmacology | 114 | 0 | 1 | 3 | 0.7 | Cn1ccnc1S | 23632915 | ||
| 6649 | 2499 | None | 0 | Human | Functional | pEC50 | = | 4.0 | 4.0 | - | 1 | UnclassifiedUnclassified |
Guide to Pharmacology | 114 | 0 | 1 | 3 | 0.7 | Cn1ccnc1S | 23632915 | ||
| CHEMBL1515 | 2499 | None | 0 | Human | Functional | pEC50 | = | 4.0 | 4.0 | - | 1 | UnclassifiedUnclassified |
Guide to Pharmacology | 114 | 0 | 1 | 3 | 0.7 | Cn1ccnc1S | 23632915 | ||
| DB00763 | 2499 | None | 0 | Human | Functional | pEC50 | = | 4.0 | 4.0 | - | 1 | UnclassifiedUnclassified |
Guide to Pharmacology | 114 | 0 | 1 | 3 | 0.7 | Cn1ccnc1S | 23632915 | ||
| 12495 | 1834 | None | 0 | Human | Functional | pEC50 | = | 4.2 | 4.2 | - | 1 | UnclassifiedUnclassified |
Guide to Pharmacology | 129 | 1 | 1 | 2 | 0.4 | C=CC1CNC(=S)O1 | 20551074 | ||
| 3034683 | 1834 | None | 0 | Human | Functional | pEC50 | = | 4.2 | 4.2 | - | 1 | UnclassifiedUnclassified |
Guide to Pharmacology | 129 | 1 | 1 | 2 | 0.4 | C=CC1CNC(=S)O1 | 20551074 | ||
| CHEMBL508652 | 1834 | None | 0 | Human | Functional | pEC50 | = | 4.2 | 4.2 | - | 1 | UnclassifiedUnclassified |
Guide to Pharmacology | 129 | 1 | 1 | 2 | 0.4 | C=CC1CNC(=S)O1 | 20551074 | ||
| 12496 | 3101 | None | 59 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 2 | 2 | UnclassifiedUnclassified |
Guide to Pharmacology | 152 | 1 | 2 | 1 | 1.3 | C1=CC=C(C=C1)NC(=S)N | 15723792 | ||
| 676454 | 3101 | None | 59 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 2 | 2 | UnclassifiedUnclassified |
Guide to Pharmacology | 152 | 1 | 2 | 1 | 1.3 | C1=CC=C(C=C1)NC(=S)N | 15723792 | ||
| CHEMBL263376 | 3101 | None | 59 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 2 | 2 | UnclassifiedUnclassified |
Guide to Pharmacology | 152 | 1 | 2 | 1 | 1.3 | C1=CC=C(C=C1)NC(=S)N | 15723792 | ||
| DB03694 | 3101 | None | 59 | Human | Functional | pEC50 | = | 5.7 | 5.7 | 2 | 2 | UnclassifiedUnclassified |
Guide to Pharmacology | 152 | 1 | 2 | 1 | 1.3 | C1=CC=C(C=C1)NC(=S)N | 15723792 | ||
Showing 1 to 50 of 60 entries
| Ligands (move mouse cursor over ligand name to see structure) | Receptor | Activity | Chemical information | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
| |
Ligands (move mouse cursor over ligand name to see structure)
| Receptor
| Activity
| Chemical information
| |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
| |
| No data available in table | ||||||||||||||||||||||
Showing 0 to 0 of 0 entries